Malignant Head and Neck Neoplasm
generalA primary or metastatic malignant neoplasm that affects the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.
16
Centers
12
Active Trials
—
Cancer Funding
Specific Cancer Types(3)
Top Centers for Malignant Head and Neck Neoplasm(16)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 58.8 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 58.8 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 58.8 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 58.8 |
| 5 | NCI Comprehensive Active Research Program | 58.8 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 58.8 |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 58.8 |
| 8 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 58.8 |
| 9 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 58.8 |
| 10 | Boston University Cancer CenterBoston, MA Active Research Program | 58.8 |
| 11 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 58.8 |
| 12 | Penn State Cancer InstituteHershey, PA Active Research Program | 58.8 |
| 13 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 36.2 |
| 14 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 36.2 |
| 15 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 36.2 |
| 16 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 36.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →